Henry Schein, Inc. (NASDAQ:HSIC) Given Consensus Rating of “Hold” by Analysts

by · The Cerbat Gem

Henry Schein, Inc. (NASDAQ:HSIC – Get Free Report) has been given a consensus rating of “Hold” by the fourteen research firms that are currently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and six have given a buy recommendation to the company. The average 12 month price objective among analysts that have covered the stock in the last year is $76.9231.

A number of analysts have recently commented on HSIC shares. Wells Fargo & Company boosted their price target on Henry Schein from $70.00 to $76.00 and gave the stock an “equal weight” rating in a research report on Wednesday, November 5th. Barrington Research set a $79.00 target price on Henry Schein and gave the stock an “outperform” rating in a report on Wednesday, November 5th. Wall Street Zen raised Henry Schein from a “hold” rating to a “buy” rating in a research note on Saturday, November 8th. Morgan Stanley lifted their price target on Henry Schein from $55.00 to $58.00 and gave the stock an “underweight” rating in a research report on Wednesday, November 5th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Henry Schein from $76.00 to $78.00 and gave the company an “overweight” rating in a research report on Wednesday, November 5th.

Get Our Latest Analysis on Henry Schein

Institutional Investors Weigh In On Henry Schein

Several institutional investors and hedge funds have recently made changes to their positions in HSIC. Alliancebernstein L.P. lifted its stake in shares of Henry Schein by 21.9% during the 1st quarter. Alliancebernstein L.P. now owns 218,340 shares of the company’s stock valued at $14,954,000 after buying an additional 39,188 shares in the last quarter. Great Lakes Advisors LLC bought a new stake in Henry Schein during the first quarter valued at about $4,477,000. Brandywine Global Investment Management LLC raised its holdings in Henry Schein by 5.4% during the second quarter. Brandywine Global Investment Management LLC now owns 79,102 shares of the company’s stock valued at $5,778,000 after acquiring an additional 4,061 shares during the period. Atria Investments Inc purchased a new position in shares of Henry Schein in the second quarter valued at about $458,000. Finally, K.J. Harrison & Partners Inc boosted its stake in shares of Henry Schein by 50.0% in the second quarter. K.J. Harrison & Partners Inc now owns 30,000 shares of the company’s stock worth $2,192,000 after acquiring an additional 10,000 shares during the period. Institutional investors own 96.62% of the company’s stock.

Henry Schein Stock Down 1.0%

NASDAQ:HSIC opened at $72.86 on Tuesday. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.40 and a quick ratio of 0.79. The firm’s 50-day moving average price is $68.43 and its 200-day moving average price is $69.44. The company has a market capitalization of $8.58 billion, a PE ratio of 23.06, a P/E/G ratio of 2.26 and a beta of 0.89. Henry Schein has a 1-year low of $60.56 and a 1-year high of $82.49.

Henry Schein (NASDAQ:HSIC – Get Free Report) last issued its quarterly earnings results on Tuesday, November 4th. The company reported $1.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.27 by $0.11. The company had revenue of $3.34 billion during the quarter, compared to analysts’ expectations of $3.28 billion. Henry Schein had a net margin of 3.02% and a return on equity of 14.76%. Henry Schein has set its FY 2025 guidance at 4.880-4.960 EPS. On average, equities analysts predict that Henry Schein will post 4.74 EPS for the current fiscal year.

Henry Schein Company Profile

(Get Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Further Reading